[Calcified aortic valve disease: association with atherosclerosis].
Calcified aortic valve disease (CAVD) is a prevalent condition, affecting 25% of people older than 65 years. CAVD and atherosclerosis share common risk factors and pathogenic mechanisms. Nevertheless, they present different pathologic lesions. The main factors involved in the pathogenesis of CAVD are genetic predisposition, the process of valvular calcification, deposition of lipoproteins, and chronic inflammation. Studies have suggested a potential benefit from early treatment with angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers, and particularly with statins. Observational studies on risk factors for the CAVD, and randomized clinical trials on primary and secondary prevention in subjects with high risk for the disease, would be necessary to improve the clinical management of CAVD.
Toro
Rocío
R
Unidad de Cardiología, Hospital Virgen de la Montaña, Cáceres, España.
Mangas
Alipio
A
Gómez
Francisco
F
D001024:Aortic Valve Stenosis / Q000453:epidemiology / Q000209:etiology / Q000235:genetics; D050197:Atherosclerosis / Q000150:complications*; D002114:Calcinosis / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology; D006349:Heart Valve Diseases / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D012307:Risk Factors